Credit Suisse’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,004
Closed -$933K 4363
2019
Q3
$933K Sell
7,004
-14,729
-68% -$1.9M ﹤0.01% 3054
2019
Q2
$2.48M Buy
+21,733
New +$2.55M ﹤0.01% 2296
2014
Q3
Sell
-112,167
Closed -$11.3M 4677
2014
Q2
$11.3M Buy
+112,167
New +$10.9M 0.01% 1307
2013
Q4
Sell
-11,639
Closed -$928K 4734
2013
Q3
$928K Hold
11,639
﹤0.01% 3021
2013
Q2
$847K Buy
+11,639
New +$870K ﹤0.01% 2925

Other funds holding ZBH

Credit Suisse's ZBH Position: Q1 2024 in Review

Credit Suisse reduced its Zimmer Biomet (ZBH) stake by 2.9% in Q1 2024, selling an estimated $1.39M and leaving 367,304 shares worth $48.1M. The position accounts for 0.05% of the portfolio, ranked #382.

Credit Suisse first reported a position in ZBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $159M in Q2 2014. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Credit Suisse held 367,304 shares of Zimmer Biomet worth $48.1M as of Q1 2024.
  • Credit Suisse sold 11,088 Zimmer Biomet shares in Q1 2024, an estimated $1.39M.
  • Zimmer Biomet made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #382 holding.
  • Credit Suisse first reported a position in Zimmer Biomet in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Zimmer Biomet position peaked at $159M in Q2 2014.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.